Image

US-based firms MicroPort Orthopedics (MPO) and MB Innovations (MBI) have entered into a multi-product development agreement for orthopedic instruments.

Under the deal, MB Innovations will initially offer design and development expertise to support development of MicroPort’s portfolio of instruments and instrument systems associated with its Fast Recovery, tissue-sparing approach to hip arthroplasty procedures.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

During the agreement period, additional development programmes will be started to develop other differentiated implants and instruments that are used for both hip and knee arthroplasty procedures.

MPO chief executive officer Ted Davis said: "Troy and his team have an established track record of innovation and product commercialisation. I’m looking forward to the impact they can have on our product offering.

"Additional development programmes will be started to develop other differentiated implants and instruments that are used for both hip and knee arthroplasty procedures."

"We have already identified the initial programmes that leverage MPO’s ongoing efforts at innovative, tissue friendly arthroplasty techniques.

See Also:

"I am confident that MBI will accelerate the pace at which we execute on our mission of delivering important and highly differentiated technologies to help surgeons care for their patients."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In January 2014, MicroPort Scientific had completed the acquisition of Wright Medical’s OrthoRecon business.

MPO is poised to capitalise on the macro trends of increasing globalisation and expanding the OrthoRecon business in the fast-growing emerging market economies, with the help of its China-based global parent.

The new products will allow MPO to enable surgeons to offer tissue-sparing surgical procedures to their patients that result in less pain and a quicker recovery from joint replacement surgery.

Image: MicroPort corporate headquarters in China. Photo: courtesy of MicroPort Scientific Corporation.